These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29344271)

  • 41. Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma.
    Zhang Y; Pan J; Xu D; Yang Z; Sun J; Sun L; Wu Y; Qiao H
    Oncol Rep; 2018 Dec; 40(6):3611-3624. PubMed ID: 30542708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients.
    Roti E; Rossi R; Trasforini G; Bertelli F; Ambrosio MR; Busutti L; Pearce EN; Braverman LE; Degli Uberti EC
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2171-8. PubMed ID: 16478817
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma.
    Kim KJ; Kim SG; Tan J; Shen X; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Xing M
    Eur J Cancer; 2020 Jan; 124():161-169. PubMed ID: 31790974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma.
    Kim WY; Kim HY; Son GS; Bae JW; Lee JB
    J Cancer Res Ther; 2014; 10(1):50-5. PubMed ID: 24762486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Papillary thyroid microcarcinoma with minimal extrathyroidal extension. Is its course so indolent that it requires a less aggressive treatment?
    Ruiz Pardo J; Ríos Zambudio A; Rodríguez González JM; Paredes Quiles M; Soriano Giménez V; Oviedo Ramírez MI; Hernández Martínez AM; Parrilla Paricio P
    Rev Clin Esp; 2021 Mar; 221(3):131-138. PubMed ID: 32216965
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Papillary Thyroid Microcarcinoma: Reclassification to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): a Retrospective Clinicopathologic Study.
    Shafique K; LiVolsi VA; Montone K; Baloch ZW
    Endocr Pathol; 2018 Dec; 29(4):339-345. PubMed ID: 30196478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Routine Lateral Level V Dissection May Not Be Necessary for Papillary Thyroid Microcarcinoma With Lateral Lymph Node Metastasis: A Retrospective Study of 252 Cases.
    Xue S; Wang P; Zhang Q; Yin Y; Guo L; Wang M; Jin M; Chen G
    Front Endocrinol (Lausanne); 2019; 10():558. PubMed ID: 31481929
    [No Abstract]   [Full Text] [Related]  

  • 48. No considerable changes in papillary thyroid microcarcinoma characteristics over a 30-year time period.
    Vlassopoulou V; Vryonidou A; Paschou SA; Ioannidis D; Koletti A; Klonaris N; Katsoulis K; Rontogianni D; Vasilopoulos C; Tsagarakis S; Tzavara I
    BMC Res Notes; 2016 Apr; 9():252. PubMed ID: 27129971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection.
    Chung YS; Kim JY; Bae JS; Song BJ; Kim JS; Jeon HM; Jeong SS; Kim EK; Park WC
    Thyroid; 2009 Mar; 19(3):241-6. PubMed ID: 19265495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
    Yang F; Zhong Q; Huang Z; Lian M; Fang J
    Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
    [No Abstract]   [Full Text] [Related]  

  • 51. Association of BRAF gene and TSHR with cervical lymph node metastasis of papillary thyroid microcarcinoma.
    Zhou C; Li J; Wang Y; Xue S; Zhang Y
    Oncol Lett; 2019 Jan; 17(1):183-194. PubMed ID: 30655754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications.
    So YK; Seo MY; Son YI
    Surgery; 2012 Feb; 151(2):192-8. PubMed ID: 21497873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
    Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
    Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative study of endoscopic thyroidectomy versus conventional open thyroidectomy in papillary thyroid microcarcinoma (PTMC) patients.
    Jeong JJ; Kang SW; Yun JS; Sung TY; Lee SC; Lee YS; Nam KH; Chang HS; Chung WY; Park CS
    J Surg Oncol; 2009 Nov; 100(6):477-80. PubMed ID: 19653245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Total thyroidectomy: safe and adequate treatment for papillary microcarcinoma of the thyroid gland.
    Uhliarova B; Hajtman A
    B-ENT; 2016 Aug; 12(2):119-124. PubMed ID: 29553616
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance.
    Kim HI; Jang HW; Ahn HS; Ahn S; Park SY; Oh YL; Hahn SY; Shin JH; Kim JH; Kim JS; Chung JH; Kim TH; Kim SW
    J Clin Endocrinol Metab; 2018 Feb; 103(2):446-451. PubMed ID: 29211863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for central neck lymph node metastasis of clinically noninvasive, node-negative papillary thyroid microcarcinoma.
    Park JP; Roh JL; Lee JH; Baek JH; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Am J Surg; 2014 Sep; 208(3):412-8. PubMed ID: 24602323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic parameters for recurrence of papillary thyroid microcarcinoma.
    Kim TY; Hong SJ; Kim JM; Kim WG; Gong G; Ryu JS; Kim WB; Yun SC; Shong YK
    BMC Cancer; 2008 Oct; 8():296. PubMed ID: 18851763
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma.
    Lim DJ; Baek KH; Lee YS; Park WC; Kim MK; Kang MI; Jeon HM; Lee JM; Yun-Cha B; Lee KW; Son HY; Kang SK
    Thyroid; 2007 Sep; 17(9):883-8. PubMed ID: 17956162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension.
    Zhang X; Zhang L; Xue S; Wang P; Chen G
    Asian J Surg; 2019 Apr; 42(4):563-570. PubMed ID: 30078501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.